Pharmaceutical / Drug Definition :
Thought to disrupt parasitic mitochondria and bind to native DNA, leading to structural changes that disrupt metabolic processes and to inhibition of gametocyte and erythrocyte forms. Destroys some gametocytes and makes others incapable of undergoing maturation division.
In the United States, Primaquine Phosphate is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Primaquine Phosphate.
FDA Label Requirements and Exceptions
FDA Import Information
Primaquine Phosphate (Primaquine Phosphate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Primaquine Phosphate (Primaquine Phosphate Suppliers)
- Processors Primaquine Phosphate
- Repackers Primaquine Phosphate
- Relabelers Primaquine Phosphate
- Exporters Primaquine Phosphate
- Importers Primaquine Phosphate
For more information about Primaquine Phosphate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.